Spero-Smith Investment Advisers’s Celgene Corp CELG Stock Holding History

Spero-Smith Investment Advisers’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.9M	Sell	18,165 -210	-1%	-$22.7K	2.55%	15
2016 Q2	$1.81M	Buy	18,375 +20	+0.1%	+$2.07K	2.26%	19
2016 Q1	$1.84M	Buy	18,355 +50	+0.3%	+$5.15K	2.3%	19
2015 Q4	$2.19M	Sell	18,305 -660	-3%	-$76.4K	2.79%	11
2015 Q3	$2.05M	Sell	18,965 -425	-2%	-$52.7K	2.78%	13
2015 Q2	$2.24M	Sell	19,390 -110	-0.6%	-$12.6K	2.55%	15
2015 Q1	$2.25M	Buy	19,500 +195	+1%	+$23.3K	2.5%	15
2014 Q4	$2.16M	Sell	19,305 -340	-2%	-$35.9K	2.46%	19
2014 Q3	$1.86M	Sell	19,645 -13,845	-41%	-$1.25M	2.16%	23
2014 Q2	$2.88M	Buy	33,490 +170	+0.5%	+$12.9K	3.25%	6
2014 Q1	$2.33M	Sell	33,320 -230	-0.7%	-$18.2K	2.75%	16
2013 Q4	$2.83M	Sell	33,550 -450	-1%	-$35.6K	3.25%	8
2013 Q3	$2.62M	Buy	34,000 +1,290	+4%	+$90.4K	3.25%	6
2013 Q2	$1.91M	Buy	+32,710	New	+$1.97M	2.38%	22

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spero-Smith Investment Advisers's CELG Position: Q3 2016 in Review

Spero-Smith Investment Advisers reduced its Celgene Corp (CELG) stake by 1.1% in Q3 2016, selling an estimated $22.7K and leaving 18,165 shares worth $1.9M. The position accounts for 2.55% of the portfolio, ranked #15.

Spero-Smith Investment Advisers first reported a position in CELG in Q2 2013 and has held it in 14 quarters since. The position peaked at $2.88M in Q2 2014. 1,277 funds tracked by Wall St. Rank hold CELG as of Q3 2016.

Spero-Smith Investment Advisers held 18,165 shares of Celgene Corp worth $1.9M as of Q3 2016.
Spero-Smith Investment Advisers sold 210 Celgene Corp shares in Q3 2016, an estimated $22.7K.
Celgene Corp made up 2.55% of Spero-Smith Investment Advisers's portfolio in Q3 2016, its #15 holding.
Spero-Smith Investment Advisers first reported a position in Celgene Corp in Q2 2013 and has held it in 14 quarters since.
Spero-Smith Investment Advisers's Celgene Corp position peaked at $2.88M in Q2 2014.
1,277 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2016.

Based on Spero-Smith Investment Advisers's 13F filing for Q3 2016, filed 31 Oct 2016.